. Author manuscript; available in PMC: 2022 Nov 28.

Published in final edited form as: Mod Pathol. 2020 Jul 28;34(1):194–206. doi: 10.1038/s41379-020-0618-9

Table 3.

Univariable association of TP53 status in MOC with clinico-pathological parameters in a survival cohort combining the Genomic Analysis of Mucinous Tumors (GAMuT) and the Ovarian Tumor Tissue Analysis (OTTA) consortium.

	TP53 normal	TP53 abnormal	p-value
MOC (N)	165	259
Age, mean (SE)	51.4 +/− 8.6	52.1 +/− 8.6	p=0.25, t =−1.15¹
Stage
I-II	136 (85.0%)	222 (89.1%)	p=0.22²
III-IV	24 (15.0%)	27 (10.8%)
Unknown	5	10
Grade
1	66 (44.9%)	84 (36.8%)	p=0.15²
2	66 (44.9%)	107 (46.9%)
3	15 (10.2%)	37 (16.2%)
Unknown	18	31

^1.

Welch t-test, 2 sided

^2.

Fisher’s exact test, 2-sided

MOC = mucinous ovarian carcinoma. SD = standard deviation